ストックスクリーナーアプリを入手
8.33
0.72%
-0.06
前日終値:
$8.39
開ける：
$8.39
24時間の取引高:
622.48K
Relative Volume:
0.35
時価総額：
$468.96M
収益：
$27.46M
当期純損益:
$-46.05M
株価収益率:
-6.4574
EPS:
-1.29
ネットキャッシュフロー:
$-33.83M
1週間 パフォーマンス:
-4.36%
1か月 パフォーマンス:
-11.38%
6か月 パフォーマンス:
-11.10%
1年 パフォーマンス:
-1.30%
1日の値動き範囲:
$8.24
$8.49
1週間の範囲:
$8.24
$9.03
52週間の値動き範囲:
$6.19
$13.16
Zevra Therapeutics Inc Stock (ZVRA) Company Profile
名前
Zevra Therapeutics Inc
セクター
電話
(321) 939-3416
住所
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
ZVRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ZVRA
Zevra Therapeutics Inc
|
8.33 | 472.34M | 27.46M | -46.05M | -33.83M | -1.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-07-02 | 開始されました | H.C. Wainwright | Buy |
| 2025-01-08 | 再開されました | Cantor Fitzgerald | Overweight |
| 2024-10-07 | 開始されました | Guggenheim | Buy |
| 2024-09-24 | 開始されました | JMP Securities | Mkt Outperform |
| 2024-09-24 | 繰り返されました | Maxim Group | Buy |
| 2024-04-02 | 繰り返されました | Maxim Group | Buy |
| 2024-03-12 | 開始されました | William Blair | Outperform |
| 2023-03-17 | 開始されました | Maxim Group | Buy |
すべてを表示
Zevra Therapeutics Inc (ZVRA) 最新ニュース
Is Zevra Therapeutics Attractively Priced After Recent Rare Disease Pipeline Progress? - Yahoo Finance
Is Zevra Therapeutics (ZVRA) Undervalued After Its Recent Share Price Pullback? - Yahoo Finance
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Schroder Investment Management Group Acquires New Position in Zevra Therapeutics, Inc. $ZVRA - MarketBeat
Zevra Therapeutics, Inc. $ZVRA Holdings Boosted by Stonepine Capital Management LLC - MarketBeat
Zevra Therapeutics Stock Drop Looks Sharp, But How Deep Can It Go? - Trefis
How Zevra Therapeutics Inc. stock performs after earningsPortfolio Value Report & Expert Approved Momentum Ideas - Newser
Behavioral Patterns of ZVRA and Institutional Flows - news.stocktradersdaily.com
Does Zevra Therapeutics’ (ZVRA) Board Turnover Subtly Recast Its Leadership and Capital Allocation Narrative? - simplywall.st
Why Zevra Therapeutics Inc. stock is favored by top institutionsDollar Strength & Stepwise Entry and Exit Trade Signals - Newser
Legal & General Group Plc Grows Stock Position in Zevra Therapeutics, Inc. $ZVRA - MarketBeat
Zevra Therapeutics (ZVRA): Evaluating Valuation Following High-Profile Board Appointment and CFO Transition - simplywall.st
Zevra Therapeutics, Inc. Announces Director and Committee Changes, Effective as of December 2, 2025 - marketscreener.com
Zevra Therapeutics appoints Alicia Secor to board of directors; announces retirement of Wendy Dixon - marketscreener.com
Zevra Therapeutics Appoints Alicia Secor to Board - TipRanks
ZVRA FinancialsIncome Statement - Quiver Quantitative
Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD - The Manila Times
Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors, Announces Retirement of Wendy Dixon - Quiver Quantitative
Zevra Therapeutics Announces Board Changes - TradingView
Zevra Therapeutics (NasdaqGS: ZVRA) names Alicia Secor to board as Wendy Dixon, PhD, retires - Stock Titan
How Zevra Therapeutics Inc. (1GDA) stock valuation compares with sectorQuarterly Portfolio Report & Growth Focused Entry Reports - Newser
How Zevra Therapeutics Inc. (1GDA) stock expands through international marketsGDP Growth & Verified High Yield Trade Plans - Newser
How institutional buying supports Zevra Therapeutics Inc. stock - moha.gov.vn
Zevra Therapeutics (ZVRA): Assessing Valuation After CFO Succession News Spurs Fresh Investor Interest - simplywall.st
(ZVRA) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
Zevra Therapeutics CFO Resignation Announced - The Globe and Mail
Zevra Therapeutics announces CFO transition - MSN
Will Zevra Therapeutics Inc. (1GDA) stock issue positive guidanceGlobal Markets & Daily Technical Forecast Reports - newser.com
Why Zevra Therapeutics Inc. stock could rally in 2025July 2025 Analyst Calls & Safe Entry Point Alerts - newser.com
Zevra Therapeutics Announces CFO Transition - citybiz
Zevra Therapeutics (ZVRA) CFO to Step Down, Shares Fall - GuruFocus
Zevra Therapeutics, Inc. announces CFO transition - marketscreener.com
[8-K] ZEVRA THERAPEUTICS, INC. Reports Material Event | ZVRA SEC FilingForm 8-K - Stock Titan
Zevra Therapeutics Announces Departure of CFO R. LaDuane Clifton, Effective December 31, 2025 - Quiver Quantitative
Zevra Therapeutics, Inc. Announces CFO Transition - GlobeNewswire
Visualizing Zevra Therapeutics Inc. stock with heatmapsJuly 2025 Market Mood & Breakout Confirmation Alerts - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock return to pre crash levelsWeekly Profit Report & Growth Focused Investment Plans - newser.com
Does Zevra Therapeutics Inc. (1GDA) stock trade below intrinsic valueEarnings Beat & Safe Entry Zone Identification - newser.com
What the charts say about Zevra Therapeutics Inc. todayQuarterly Profit Summary & Long-Term Capital Growth Ideas - newser.com
Is Zevra Therapeutics Inc. (1GDA) stock a top hedge fund pick2025 Sector Review & High Yield Stock Recommendations - newser.com
How sentiment analysis helps forecast Zevra Therapeutics Inc.July 2025 Outlook & Short-Term High Return Strategies - newser.com
Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Can Zevra Therapeutics Inc. stock beat market expectations this quarterBuy Signal & Technical Pattern Based Signals - newser.com
Zevra Therapeutics Inc (ZVRA) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):